Development of artemisinin drugs in the treatment of autoimmune diseases
Authors:
- Yanwei WuYWYanwei Wu
- Wei TangWTWei Tang
- Jianping ZuoJZJianping Zuo
- 1 January 2016
- journal article
- Published by Elsevier in Science Bulletin
- Vol. 61 (1) , 37-41
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Artemisinins: Pharmacological actions beyond anti-malarialPharmacology & Therapeutics, 2014
- Qinghaosu (artemisinin): Chemistry and pharmacologyActa Pharmacologica Sinica, 2012
- SM934, a water-soluble derivative of arteminisin, exerts immunosuppressive functions in vitro and in vivoInternational Immunopharmacology, 2009
- SM905, an artemisinin derivative, inhibited NO and pro-inflammatory cytokine production by suppressing MAPK and NF-κB pathways in RAW 264.7 macrophagesActa Pharmacologica Sinica, 2009
- Suppressive effect of a novel water-soluble artemisinin derivative SM905 on T cell activation and proliferation in vitro and in vivoEuropean Journal of Pharmacology, 2007
- Investigation of the immunosuppressive activity of artemether on T‐cell activation and proliferationBritish Journal of Pharmacology, 2007
- Synthesis and immunosuppressive activity of new artemisinin derivatives. Part 2: 2-[12(β or α)-Dihydroartemisinoxymethyl(or 1′-ethyl)]phenoxyl propionic acids and estersBioorganic & Medicinal Chemistry, 2006
- A novel artemisinin derivative, 3-(12-beta-artemisininoxy) phenoxyl succinic acid (SM735), mediates immunosuppressive effects in vitro and in vivo1Acta Pharmacologica Sinica, 2005
- Synthesis and Immunosuppressive Activity of New Artemisinin Derivatives. 1. [12(β or α)-Dihydroartemisininoxy]phen(ox)yl Aliphatic Acids and EstersJournal of Medicinal Chemistry, 2005
- Effects of artemisinin, dihydroartemisinin and arteether on immune responses of normal miceInternational Journal of Immunopharmacology, 1990